𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Highlights on the Development of A2A Adenosine Receptor Agonists and Antagonists

✍ Scribed by Gloria Cristalli; Barbara Cacciari; Diego Dal Ben; Catia Lambertucci; Stefano Moro; Giampiero Spalluto; Rosaria Volpini

Publisher
John Wiley and Sons
Year
2007
Weight
11 KB
Volume
38
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CoMFA Study on Adenosine A2A Receptor Ag
CoMFA Study on Adenosine A2A Receptor Agonists
✍ Doytchinova, Irini ;Valkova, Iva ;Natcheva, Roumiana πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 1 views

A step-wise CoMFA-based procedure was applied to a series of 51 C2-oxyadenosines in order to select the most predictive conformation for binding to A 2A adenosine receptor. The highest correlation and predictive power was found for conformers with the side chain at the 2position oriented in the dire

ChemInform Abstract: Antiparkinsonian Ef
ChemInform Abstract: Antiparkinsonian Effects of Novel Adenosine A2A Receptor Antagonists.
✍ Anna Drabczynska; Malgorzata Zygmunt; Jacek Sapa; Barbara Filipek; Christa E. Mu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons βš– 25 KB πŸ‘ 1 views

## Abstract A series of 11 known pyrimidopurinedione derivatives of type (IV) and the new compound (III) are tested for their antiparkinsonian activities.

A2A-selective adenosine receptor antagon
A2A-selective adenosine receptor antagonists: Development of water-soluble prodrugs and a new tritiated radioligand
✍ Christa E. MΓΌller; Roland Sauer; Yuris Maurinsh; Rosa Huertas; Friederike FΓΌlle; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 2 views

A 2A adenosine receptor (AR) antagonists are promising new drugs for the treatment of Parkinson's disease. Further potential therapeutic indications for A 2A AR antagonists include dementias, ischemias, and pain. Potent, selective A 2A AR antagonists have been developed, but their generally low wate